Search for: "BIOGEN INC."
Results 141 - 160
of 259
Sorted by Relevance
|
Sort by Date
13 Mar 2024, 7:24 pm
Biogen MA Inc. is thus relying upon the premarket activities of Biogen, Inc. to support application for patent term extension. [read post]
23 Sep 2009, 7:03 am
" Like all drugs, Tysabri, which is marketed by Biogen Idec Inc. and Elan Corp. [read post]
29 Jun 2012, 5:00 am
Biogen IDEC, Inc., 2012 WL 2417722, slip op. [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property) [read post]
25 May 2017, 8:40 am
Roche said it was investigating a case of Progressive Multifocal Leukoencephalopathy (PML) in a patient previously being treated for three years with Biogen Inc’s Tysabri and who had received a single dose of Ocrevus in February. [read post]
15 Mar 2011, 3:52 pm
(Biogen, defendant). [read post]
3 Apr 2024, 10:56 am
Two recent examples are the $337.45 million settlement with Booz Allen Holding Corporation in 2023 for improperly billing certain costs to its government contracts; and the $900 million settlement with Biogen, Inc. in 2022 for paying kickbacks to physicians so they would prescribe Biogen drugs. [read post]
19 Apr 2013, 9:25 pm
Biogen Idec Inc., C.A. [read post]
3 Nov 2011, 12:48 pm
Biogen IDEC, and CyberSource Corp. v. [read post]
5 Sep 2015, 11:58 am
A different three-judge panel on Sept. 1 said information of a clinical trial wasn’t evidence that could be used to challenge Biogen Inc. [read post]
22 Mar 2012, 4:55 am
Biogen Idec, 659 F.3d 1057 (Fed. [read post]
12 Nov 2008, 7:00 pm
Biogen IDEC Inc., 537 F.3d 35 (1st Cir. 2008). [read post]
23 Jul 2009, 2:30 am
Kitchin J bases his reasoning on the House of Lords decision in Lundbeck, which he sees as reaffirming the reasoning in Biogen, both support the basic rule for sufficiency (see paras 233-234). [read post]
30 Aug 2013, 9:43 am
” Biogen, Inc. v. [read post]
20 Sep 2021, 3:31 pm
Process-by-Product Claim: In Biogen MA Inc., Petitioner v. [read post]
12 Nov 2013, 6:17 am
Hacon, with willingness, a scientific background and no stranger to the Patents Court or the EPO (where he has represented Biogen, Genentech and Novartis), quickly became the heir apparent for the empty post. [read post]
30 Jun 2014, 11:04 am
Biogen Idec, Inc., 2014 WL 2882104 (W.D.N.Y. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term… [read post]
3 Mar 2017, 7:25 am
Inc. [2007] EWHC 1900 (Pat) and that describing these declarat [read post]
5 Jul 2010, 11:19 am
Biogen Idec – to the Federal Circuit to reconsider the cases in light of the Bilski decision. [read post]
